{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:47:33Z","timestamp":1790768853943,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T00:00:00Z","timestamp":1510617600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s00345-017-2129-y","type":"journal-article","created":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T09:28:14Z","timestamp":1510651694000},"page":"271-276","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Safety and feasibility study of holmium laser enucleation of the prostate (HOLEP) on patients receiving dual antiplatelet therapy (DAPT)"],"prefix":"10.1007","volume":"36","author":[{"given":"Jie","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4672-5536","authenticated-orcid":false,"given":"Wei","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,14]]},"reference":[{"key":"2129_CR1","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","volume":"50","author":"DE Irwin","year":"2006","unstructured":"Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z et al (2006) Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 50:1306\u20131314","journal-title":"Eur Urol"},{"key":"2129_CR2","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1093\/eurheartj\/ehv203","volume":"36","author":"RA Byrne","year":"2015","unstructured":"Byrne RA, Serruys PW, Baumbach A et al (2015) Report of a European Society of Cardiology-European Association of Percutaneous Cardiovascular Interventions task force on the evaluation of coronary stents in Europe: executive summary. Eur Heart J 36:2608\u20132620","journal-title":"Eur Heart J"},{"key":"2129_CR3","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","volume":"35","author":"S Windecker","year":"2014","unstructured":"Windecker S, Kolh P, Alfonso F et al (2014) ESC\/EACTS guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 35:2541\u20132619","journal-title":"Eur Heart J"},{"key":"2129_CR4","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/j.jacc.2017.02.012","volume":"69","author":"S Banerjee","year":"2017","unstructured":"Banerjee S, Angiolollo DJ, Boden WE et al (2017) Use of anti platelet therapy\/DAPT for post-PCI patients undergoing noncardiac surgery. J Am Coll Cardiol 69:1861\u20131870","journal-title":"J Am Coll Cardiol"},{"key":"2129_CR5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.juro.2008.03.039","volume":"180","author":"X Yu","year":"2008","unstructured":"Yu X, Elliott SP, Wilt TJ, McBean AM (2008) Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies. J Urol 180:241\u2013245","journal-title":"J Urol"},{"key":"2129_CR6","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.urology.2016.10.015","volume":"99","author":"RA Pathak","year":"2017","unstructured":"Pathak RA, Broderick GA, Igel TC et al (2017) Impact of minimally invasive benign prostatic hyperplasia therapies on 30- and 90-Day postoperative office encounters. Urology 99:186\u2013191","journal-title":"Urology"},{"key":"2129_CR7","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00345-015-1639-8","volume":"34","author":"AM Elshal","year":"2016","unstructured":"Elshal AM, Mekkawy R, Laymon M et al (2016) Holmium laser enucleation of the prostate for treatment for large-sized benign prostate hyperplasia; is it a realistic endourologic alternative in developing country? World J Urol 34:399\u2013405","journal-title":"World J Urol"},{"key":"2129_CR8","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/1756287213511509","volume":"6","author":"M Cynk","year":"2014","unstructured":"Cynk M (2014) Holmium laser enucleation of the prostate: a review of the clinical trial evidence. Ther Adv Urol 6:62\u201373","journal-title":"Ther Adv Urol"},{"key":"2129_CR9","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000200786","volume":"82","author":"RM Mavuduru","year":"2009","unstructured":"Mavuduru RM, Mandal AK, Singh SK et al (2009) Comparison of HoLEP and TURP in terms of efficacy in the early postoperative period and perioperative morbidity. Urol Int 82:130\u2013135","journal-title":"Urol Int"},{"key":"2129_CR10","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1089\/end.2016.0070","volume":"30","author":"MM EI Tayeb","year":"2016","unstructured":"EI Tayeb MM, Jacob JM, Bhojani N, Bammerlin E, Lingeman JE (2016) Holmium laser enucleation of the prostate in patients requiring anticoagulation. J Endourol 30:805\u2013809","journal-title":"J Endourol"},{"key":"2129_CR11","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.eururo.2014.12.038","volume":"67","author":"C Gratzke","year":"2015","unstructured":"Gratzke C, Bachmann A, Descazeaud A et al (2015) EAU guide-lines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 67:1099\u20131109","journal-title":"Eur Urol"},{"key":"2129_CR12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00345-010-0566-y","volume":"29","author":"C Mamoulakis","year":"2011","unstructured":"Mamoulakis C, Efthimiou I, Kazoulis S, Christoulaskis I, Sofras F (2011) The modified Clavien classification system: a standardized platform for reporting complications in transurethral resection of the prostate. World J Urol 29:205\u2013210","journal-title":"World J Urol"},{"key":"2129_CR13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1477-7819-1-6","volume":"1","author":"RL Kuo","year":"2003","unstructured":"Kuo RL, Paterson RF, Kim SC et al (2003) Holmium laser enucleation of the prostate (HoLEP): a technical update. World J Surg Oncol 1:6","journal-title":"World J Surg Oncol"},{"key":"2129_CR14","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.eururo.2005.12.042","volume":"50","author":"J Rassweiler","year":"2006","unstructured":"Rassweiler J, Teber D, Kuntz R, Hofmann R (2006) Complications of transurethral resection of the prostate (TURP)\u2014incidence, management, and prevention. Eur Urol 50:969\u2013979","journal-title":"Eur Urol"},{"key":"2129_CR15","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00345-010-0561-3","volume":"29","author":"A Descazeaud","year":"2011","unstructured":"Descazeaud A, Robert G, Lebdai S et al (2011) Impact of oral anticoagulation on morbidity of transurethral resection of the prostate. World J Urol 29:211\u2013216","journal-title":"World J Urol"},{"key":"2129_CR16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1464-410X.2011.10686.x","volume":"108","author":"K Taylor","year":"2011","unstructured":"Taylor K, Filgate R, Guo DY, Macneil F (2011) A retrospective study to assess the morbidity associated with transurethral prostatectomy in patients on antiplatelet or anticoagulant drugs. BJU Int 108:45\u201350","journal-title":"BJU Int"},{"key":"2129_CR17","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.eururo.2007.08.036","volume":"53","author":"RM Kuntz","year":"2008","unstructured":"Kuntz RM, Lehrich K, Ahyai SA (2008) Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100\u00a0grams: 5-year follow-up results of a randomised clinical trial. Eur Urol 53:160\u2013166","journal-title":"Eur Urol"},{"key":"2129_CR18","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1464-410X.2011.10359.x","volume":"109","author":"PJ Gilling","year":"2012","unstructured":"Gilling PJ, Wilson LC, King CJ et al (2012) Long-term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate: results at 7\u00a0years. BJU Int 109:408\u2013411","journal-title":"BJU Int"},{"key":"2129_CR19","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1089\/end.2005.19.1196","volume":"19","author":"JS Sandhu","year":"2005","unstructured":"Sandhu JS, Ng CK, Gonzalez RR, Kaplan SA, Te AE (2005) Photoselective laser vaporization prostatectomy in men receiving anticoagulants. J Endourol 19:1196\u20131198","journal-title":"J Endourol"},{"key":"2129_CR20","doi-asserted-by":"crossref","first-page":"178","DOI":"10.4111\/kju.2011.52.3.178","volume":"52","author":"JH Sohn","year":"2011","unstructured":"Sohn JH, Choi YS, Kim SJ et al (2011) Effectiveness and safety of photoselective vaporization of the prostate with the 120\u00a0W HPS greenlight laser in benign prostatic hyperplasia patients taking oral anticoagulants. Korean J Urol 52:178\u2013183","journal-title":"Korean J Urol"},{"key":"2129_CR21","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/bju.12674","volume":"115","author":"CD Jaeger","year":"2015","unstructured":"Jaeger CD, Mitchell CR, Mynderse LA, Krambeck AE (2015) Holmium laser enucleation (HoLEP) and photoselective vaporisation of the prostate (PVP) for patients with benign prostatic hyperplasia (BPH) and chronic urinary retention. BJU Int 115:295\u2013299","journal-title":"BJU Int"},{"key":"2129_CR22","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000343549","volume":"7","author":"CV Bishop","year":"2013","unstructured":"Bishop CV, Liddell H, Ischia J et al (2013) Holmium laser enucleation of the prostate: comparison of immediate postoperative outcomes in patients with and without antithrombotic therapy. Curr Urol 7:28\u201333","journal-title":"Curr Urol"},{"key":"2129_CR23","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","volume":"371","author":"L Mauri","year":"2014","unstructured":"Mauri L, Kereiakes DJ, Yeh RW et al (2014) Twelve or 30\u00a0months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med 371:2155\u20132166","journal-title":"N Engl J Med"},{"key":"2129_CR24","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.amjcard.2009.07.002","volume":"104","author":"G Tanzilli","year":"2009","unstructured":"Tanzilli G, Greco C, Pelliccia F et al (2009) Effectiveness of two-year clopidogrel\u00a0+\u00a0aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study). Am J Cardiol 104:1357\u20131361","journal-title":"Am J Cardiol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-017-2129-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-017-2129-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-017-2129-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,5]],"date-time":"2018-02-05T04:15:15Z","timestamp":1517804115000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-017-2129-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,14]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["2129"],"URL":"https:\/\/doi.org\/10.1007\/s00345-017-2129-y","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,14]]}}}